Bottom line
HCPSX vs XLV: the short answer
HCPSX (Health Care Ultrasector Profund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.
XLV is cheaper at 0.08% vs 2.76% — a difference of $268 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +5.3% for HCPSX (reporting dates differ).
Updated Nov 19, 2026
HCPSX vs XLV side by side
| HCPSX | XLV | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | ProShares | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.76% | 0.08% |
| Annual cost per $10k | $276 | $8 |
| 10-yr cost on $10k (prospectus) | $3,090 | $103 |
| Max front load | — | None |
| 12b-1 fee | 1% | 0.02% |
| 1-yr return | −2.4% | +14.5% |
| 5-yr return (annualized) | +5.3% | +8.1% |
| 10-yr return (annualized) | +8.1% | +9.8% |
| Best quarter | — | +14.5% |
| Worst quarter | — | −12.7% |
| Net assets (fund) | $12.1M | $40.6B |
| Number of holdings | 69 | 65 |
| Portfolio turnover | 99% | 2% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
18 of HCPSX's top 25 holdings also appear in XLV's top 25.
| Holding | HCPSX | XLV |
|---|---|---|
| Eli Lilly & Company | 11.83% | 16.51% |
| Johnson & Johnson | 8.03% | 10.64% |
| Abbvie Inc | 5.77% | 7.74% |
| Unitedhealth Group Inc | 4.90% | 6.57% |
| Merck & Company Inc | 4.19% | 5.52% |
| Thermo Fisher Scientific Inc | 2.78% | 3.24% |
| Amgen Inc | 2.71% | 3.40% |
| Abbott Laboratories | 2.40% | 2.75% |
| Gilead Sciences Inc | 2.10% | 2.73% |
| Pfizer Inc | 1.86% | 2.39% |
| Bristol-myers Squibb Company | 1.74% | 2.05% |
| Cvs Health Corp | 1.73% | 2.30% |
| Intuitive Surgical Inc | 1.63% | 2.45% |
| Danaher Corp | 1.60% | 2.09% |
| Vertex Pharmaceuticals Inc | 1.57% | 2.19% |
Source: SEC Form N-PORT
HCPSX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between HCPSX and XLV?
HCPSX (Health Care Ultrasector Profund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. XLV is cheaper at 0.08% vs 2.76% — a difference of $268 a year per $10,000 invested.
Which is cheaper, HCPSX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both HCPSX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.